The Clinical Neuroplasticity and Neurotransmitters (CNNT) Study Section reviews applications which use experimental in vitro, small animal and subhuman primate models to understand the mechanisms of epilepsy, spinal cord injury and neurodegeneration including peripheral neuropathies, Parkinson’s disease (PD), dystonia, and amyotrophic lateral sclerosis (ALS).
The List of Reviewers lists all present, whether permanent or temporary, to provide the full scope of expertise present on that date. Lists are posted 30 days before the meeting and are tentative, pending any last minute changes.
The membership panel is a list of chartered members only.
- Development of an understanding of basic mechanisms/pathologies of epilepsy, epileptogenesis, spinal cord injury, Parkinson’s disease neurodegeneration and diabetic neuropathy using rodent and non-human primate models.
- Evaluation of the alteration synaptic functions, plasticity and adult neurogenesis in the above-mentioned disease models using anatomical, electrophysiological and optogenetic technologies.
- Computer modeling methodologies to evaluate synaptic connectivity changes relating to epilepsy, spinal cord injury and Parkinson’s disease.
- Translational pharmacologic approaches to epilepsy, spinal cord injury and Parkinson’s disease.
- The effects of long-term drug administration on CNS activity and structure (e.g., L-DOPA)
- Changes in signal transduction pathways that accompany long term changes of excitatory and inhibitory cellular and network activity in spinal cord injury, epilepsy and Parkinson’s disease
- Epigenetic processes dictating changes in neurogenesis and changes in connectivity following excitation inhibition imbalances.
- Applications leading to the understanding of molecular changes in AMPA, GABA, NMDA and GLUR receptors in injury and alterations of excitation and inhibition.
- The development of stem cell lines and viral vectors for gene therapy approaches.
- Small animal imaging techniques MRI, DTI, MRS to follow connectivity and tracking stem cell transplants.
Shared Interests and Overlaps
CNNT vs Acute Neural Injury and Epilepsy (ANIE) have shared interests in epilepsy, SCI - ANIE is the main study section to review clinical and human-subject based studies clinical and human-subject based vs CNNT reviews those applications focused on the use of experimental and animal models.
Basic mechanisms of structure and function of cortical and cerebellar microcircuitry involved in voluntary and involuntary movements (Sensorimotor Integration Study Section [SMI] ) vs. involvement of spinal cord injury (CNNT)
Cellular and molecular mechanisms of neural induction in normal development (Neurogenesis and Cell Fate Study Section [NCF]) vs. involvement of spinal cord injury and epilepsy (CNNT)
Whole animal studies to examine mechanisms and involvement of specific molecules and pathways in PD, HD, and ALS (Chronic Dysfunction and Integrative Neurodegeneration [CDIN]), in vitro and in vivo studies from animal models (e.g., electrophysiological studies) for these diseases (CNNT).
Animal models of Parkinson’s disease mechanisms and treatment modalities such as deep brain stimulation (CNNT)vs. human-subject based studies of Parkinson’s disease (Clinical Neuroscience and Neurodegeneration [CNN]).
Non-invasive recordings of spinal cord injury, epilepsy and Parkinson’s disease (CNNT) versus invasive, long-term recordings of spinal cord injury, epilepsy and Parkinson’s disease (Bioengineering of Neuroscience, Vision and Low Vision Technologies [BNVT])
CNNT and Neurodifferentiation, Plasticity, and Regeneration (NDPR) have shared interests in neuroplasticity and regeneration. Applications focusing predominantly on basic cellular and molecular mechanisms of synaptogenesis, plasticity and regeneration may be reviewed in NDPR.